Phase 1, Single Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of MEDI5884

NCT03001297 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL: Placebo
BIOLOGICAL: MEDI5884 Dose 1
BIOLOGICAL: MEDI5884 Dose 2
BIOLOGICAL: MEDI5884 Dose 3
BIOLOGICAL: MEDI5884 Dose 4

Sponsor

MedImmune LLC